Literature DB >> 3291628

Neuronal ceroid-lipofuscinoses in childhood.

P Santavuori1.   

Abstract

Neuronal Childhood types of ceroid-lipofuscinoses (NCL) are reviewed. All three main types, infantile, late infantile and juvenile, are progressive encephalopathies characterized by neural and extraneural accumulation of ceroid- and lipofuscin like storage cytosomes. The pathogenesis of NCL is unknown. A disturbance of the peroxidation of polyunsaturated fatty acids and a defect in the processing and turn-over of the glycoproteins in the lysosomal membrane are those hypotheses which have been most widely investigated. Reduced membrane lipids and reduced membrane fluidity have recently been detected. Prenatal diagnosis, based on the characteristic ultrastructural findings, is possible in all types.

Entities:  

Mesh:

Year:  1988        PMID: 3291628     DOI: 10.1016/s0387-7604(88)80075-5

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  66 in total

Review 1.  Neuronal ceroid lipofuscinoses: a review.

Authors:  N Nardocci; F Cardona
Journal:  Ital J Neurol Sci       Date:  1998-10

Review 2.  [Genetics of neuronal ceroidlipofuscinoses. Aspects of genetic counseling].

Authors:  M N Preising; B Lorenz
Journal:  Ophthalmologe       Date:  2010-07       Impact factor: 1.059

3.  Two motifs target Batten disease protein CLN3 to lysosomes in transfected nonneuronal and neuronal cells.

Authors:  Aija Kyttälä; Gudrun Ihrke; Jouni Vesa; Michael J Schell; J Paul Luzio
Journal:  Mol Biol Cell       Date:  2003-12-29       Impact factor: 4.138

4.  Lithium rescues the impaired autophagy process in CbCln3(Δex7/8/Δex7/8) cerebellar cells and reduces neuronal vulnerability to cell death via IMPase inhibition.

Authors:  Jae-Woong Chang; Hyunwoo Choi; Susan L Cotman; Yong-Keun Jung
Journal:  J Neurochem       Date:  2011-01-19       Impact factor: 5.372

5.  Spectrum of mutations in the Batten disease gene, CLN3.

Authors:  P B Munroe; H M Mitchison; A M O'Rawe; J W Anderson; R M Boustany; T J Lerner; P E Taschner; N de Vos; M H Breuning; R M Gardiner; S E Mole
Journal:  Am J Hum Genet       Date:  1997-08       Impact factor: 11.025

Review 6.  Correlations between genotype, ultrastructural morphology and clinical phenotype in the neuronal ceroid lipofuscinoses.

Authors:  Sara E Mole; Ruth E Williams; Hans H Goebel
Journal:  Neurogenetics       Date:  2005-09-28       Impact factor: 2.660

7.  Treatment of the Ppt1(-/-) mouse model of infantile neuronal ceroid lipofuscinosis with the N-methyl-D-aspartate (NMDA) receptor antagonist memantine.

Authors:  Rozzy Finn; Attila D Kovács; David A Pearce
Journal:  J Child Neurol       Date:  2013-09       Impact factor: 1.987

8.  Rapid diagnostic test for the major mutation underlying Batten disease.

Authors:  I Järvelä; H M Mitchison; P B Munroe; A M O'Rawe; S E Mole; A C Syvänen
Journal:  J Med Genet       Date:  1996-12       Impact factor: 6.318

9.  Subdural fluid collections in patients with infantile neuronal ceroid lipofuscinosis.

Authors:  Sondra W Levin; Eva H Baker; Andrea Gropman; Zenaide Quezado; Ning Miao; Zhongjian Zhang; Alice Jollands; Matteo Di Capua; Rafael Caruso; Anil B Mukherjee
Journal:  Arch Neurol       Date:  2009-12

10.  The role of nonsense-mediated decay in neuronal ceroid lipofuscinosis.

Authors:  Jake N Miller; Chun-Hung Chan; David A Pearce
Journal:  Hum Mol Genet       Date:  2013-03-28       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.